Andrographolide promotes pancreatic duct cells differentiation into insulin-producing cells by targeting PDX-1
- PMID: 31887289
- DOI: 10.1016/j.bcp.2019.113785
Andrographolide promotes pancreatic duct cells differentiation into insulin-producing cells by targeting PDX-1
Abstract
Regeneration of β-cells by differentiation of pancreatic progenitor cells has the potential to fundamentally solve the problems of the loss of β-cell function and mass during disease progression in both type 1 or 2 diabetes. Therefore, discovery of novel differentiation inducers to promote islet regeneration is of great significance. Pancreatic and duodenal homeobox1 (PDX-1) is a key transcription factor that promotes the development and maturation of pancreatic β-cells. To screen potential novel small molecules for enhancing differentiation of PNAC-1 cells, a human pancreatic ductal cell lines into insulin-producing cells (IPCs), we developed a high-throughput screening method through fusing the PDX-1 promoter region with a luciferase reporter gene. We screened and identified that andrographolide named C1037 stimulates PDX-1 expression in both mRNA and protein level and significantly promotes PANC-1 cells differentiation into IPCs as compared with that of control cells. The therapeutic effect of C037 in Streptozotocin induced diabetic mouse model through differentiation of pancreatic ductal cells into insulin positive islets was also observed. Our study provides a novel method to screen compounds regulating the differentiation of pancreatic progenitor cells having the potential of enhancing islet regeneration for diabetes therapy.
Keywords: Andrographolide; Differentiation; Islet regeneration; PDX-1; Pancreatic duct cells.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.Phytomedicine. 2014 Feb 15;21(3):233-9. doi: 10.1016/j.phymed.2013.09.008. Epub 2013 Oct 28. Phytomedicine. 2014. PMID: 24176839
-
Pancreatic effect of andrographolide isolated from Andrographis paniculata (Burm. f.) Nees.Pak J Biol Sci. 2014 Jan 1;17(1):22-31. doi: 10.3923/pjbs.2014.22.31. Pak J Biol Sci. 2014. PMID: 24783774
-
Naringin (4',5,7-Trihydroxyflavanone 7-Rhamnoglucoside) Attenuates β-Cell Dysfunction in Diabetic Rats through Upregulation of PDX-1.Cells Tissues Organs. 2018;206(3):133-143. doi: 10.1159/000496506. Epub 2019 Mar 18. Cells Tissues Organs. 2018. PMID: 30884485
-
Role of PDX-1 and MafA as a potential therapeutic target for diabetes.Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S127-37. doi: 10.1016/j.diabres.2007.01.046. Epub 2007 Apr 20. Diabetes Res Clin Pract. 2007. PMID: 17449132 Review.
-
PDX-1 functions as a master factor in the pancreas.Front Biosci. 2008 May 1;13:6406-20. doi: 10.2741/3162. Front Biosci. 2008. PMID: 18508668 Review.
Cited by
-
AMPKα2 Overexpression Reduces Cardiomyocyte Ischemia-Reperfusion Injury Through Normalization of Mitochondrial Dynamics.Front Cell Dev Biol. 2020 Aug 27;8:833. doi: 10.3389/fcell.2020.00833. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32984328 Free PMC article.
-
SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury.Aging (Albany NY). 2020 Jul 28;12(16):16224-16237. doi: 10.18632/aging.103644. Epub 2020 Jul 28. Aging (Albany NY). 2020. PMID: 32721927 Free PMC article.
-
PDX-1: A Promising Therapeutic Target to Reverse Diabetes.Biomolecules. 2022 Nov 30;12(12):1785. doi: 10.3390/biom12121785. Biomolecules. 2022. PMID: 36551213 Free PMC article. Review.
-
An Insight into Vital Genes Responsible for β-cell Formation.Adv Exp Med Biol. 2024;1450:1-27. doi: 10.1007/5584_2023_778. Adv Exp Med Biol. 2024. PMID: 37432546
-
Long noncoding RNA LINC00844-mediated molecular network regulates expression of drug metabolizing enzymes and nuclear receptors in human liver cells.Arch Toxicol. 2020 May;94(5):1637-1653. doi: 10.1007/s00204-020-02706-5. Epub 2020 Mar 28. Arch Toxicol. 2020. PMID: 32222775 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical